MUZEU Muzero outlines new crosssector strategic acquisition priorities during its latest quarterly earnings call AIDX 2020 Biolabs highlights rising clinical test adoption as core growth driver in latest quarterly earnings ELE Elemental stock gains nearly 2 percent even after fourth quarter 2025 earnings trail far behind analyst estimates